Insulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions
The DOI matches its Crossref record.
Abstract
Insulin resistance has been recognized as an inflammatory disease based on the scientific evidence collected over the last decade. Inflammatory markers like CRP, PAI-1, IL-6 are present in higher concentrations in insulin resistant people than in normal people. Mechanisms, linking inflammation to insulin resistance are being explored and progress has been made in this direction. TNFalpha has been shown to be responsible for insulin resistance in obese subjects. Macronutrient intake may also induce inflammation whereas fasting has anti-inflammatory effects. Insulin itself has been found to be anti-inflammatory and this action may be useful in many disease states. Thiazolidinediones, such as rosiglitazone that act primarily as insulin sensitisers, have a profound anti-inflammatory and potentially antiatherosclerotic activity. These effects may be of considerable clinical significance if sustained during long-term therapy, given the morbidity and mortality associated with atherosclerosis, the major complication of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
DeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Insulin Resistance, Obesity and Lipotoxicity
Yazıcı, D., & Sezer, H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_12 · Cited by 499
An immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394
Solomon, D. H. (2011) · JAMA · doi:10.1001/jama.2011.878 · Cited by 393
The Development of Porcine Models of Obesity and the Metabolic Syndrome ,
Spurlock, M. E., & Gabler, N. K. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.2.397 · Cited by 366
Ajuwon, K. M., & Spurlock, M. E. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00397.2004 · Cited by 348
Tranilast: A review of its therapeutic applications
Darakhshan, S., & Pour, A. B. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2014.10.009 · Cited by 322
Kones, R. (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 259
Pulmonary Function and Abdominal Adiposity in the General Population
Ochs-Balcom, H. M., Grant, B. J. B., Muti, P., Sempos, C. T., Freudenheim, J. L., Trevisan, M., Cassano, P. A., Iacoviello, L., & Schünemann, H. J. (2006) · Chest · doi:10.1378/chest.129.4.853 · Cited by 253
Al-Khalili, L., Forsgren, M., Kannisto, K., Zierath, J. R., Lönnqvist, F., & Krook, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1741-3 · Cited by 78
“PPAR gamma agonists such as rosiglitazone) act primarily on peripheral insulin sensitivity and also have positive effects on fasting levels of NEFA and inflammatory markers [26–28].”
BackgroundSanchez-Autet, M., Arranz, B., Sierra, P., Safont, G., Garcia-Blanco, A., de la Fuente, L., Garriga, M., Marín, L., & García-Portilla, M. P. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2013089 · Cited by 15
Metadata
- Authors
- Garg, R., Tripathy, D., & Dandona, P.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-08-01
- Volume
- 4
- Issue
- 6
- Pages
- 487-492
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2147612813
- Cited by
- 96
- References
- 0
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.